Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

Status unconfirmed · Not applicable

Conditions studied: Anemia, Mortality

In brief

The investigators hypothesize that the post-hospitalized patient status is characterized by subacute and reversible metabolic and hematological changes that, if addressed and treated in a timely manner, would result in a reduced risk for repeat hospitalization. Consequently, a structured quality improvement program, focused on increasing adherence to company wide anemia management policies (ie hemoglobin monitoring within the first 3-5 days post-hospitalization, followed by an appropriate EPO dose modification within the 7 days post-hospitalization), will significantly decrease the risk of hospital re-admission in the 30 days after discharge.

Key facts

Study ID

NCT01017627

Run by

Fresenius Medical Care North America

People needed

1500

Starts

2009-11-01

Expected to finish

2010-12-01

Last updated by the study team

2010-04-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age ≥ 18
• resumption of routine outpatient chronic hemodialysis within three days of discharge from hospital admission
• enrolled in a facility-based anemia management program

You may not qualify if…

• enrolled in hospice
• previous hospitalization within the past 30 days (ie. patients discharged from a repeat hospitalization)
• anticipated discharge from the outpatient dialysis facility within 30 days (ie anticipated transfer to another facility or hospice)

Where it is running

• Denver Central — Denver, Colorado, United States
• St. John's — Jacksonville, Florida, United States
• JAX Beach — Jacksonville, Florida, United States
• Prairie — Chicago, Illinois, United States
• Tri Counties — Decatur, Indiana, United States
• Huntington — Huntington, Indiana, United States
• Floyd County — New Albany, Indiana, United States
• South Louisville — Louisville, Kentucky, United States
• Breaux Bridge — Breaux Bridge, Louisiana, United States
• Delta — Delta, Louisiana, United States
• East Lafayette — Lafayette, Louisiana, United States
• Methuen — Methuen, Massachusetts, United States
• Roxbury — Roxbury, Massachusetts, United States
• Battle Creek — Battle Creek, Michigan, United States
• East Lansing — East Lansing, Michigan, United States
• Oshtemo — Kalamazoo, Michigan, United States
• Lansing — Lansing, Michigan, United States
• Saganaw Riverside — Saginaw, Michigan, United States
• Saginaw — Saginaw, Michigan, United States
• Eupora — Eupora, Mississippi, United States
• Meridian — Meridian, Mississippi, United States
• Yokna River — Oxford, Mississippi, United States
• Independence Centerpoint — Independence, Missouri, United States
• Desert Inn — Las Vegas, Nevada, United States
• South Pecos — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.